Lixia Cao

1 Patent

• US126054572026

  Modified EGFR Antibody with Reduced Affinity, Drug Conjugate, and Use Thereof

  BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., Ltd.

  0 cites